相似文献
1
How to tackle antimalarial resistance?
EMBO Mol Med. 2017 Feb;9(2):133-134. doi: 10.15252/emmm.201607295.
2
Drug-resistant malaria advances in Mekong.
Science. 2017 Oct 13;358(6360):155-156. doi: 10.1126/science.358.6360.155.
3
Evidence of Artemisinin-Resistant Plasmodium falciparum Malaria in Eastern India.
N Engl J Med. 2018 Nov 15;379(20):1962-1964. doi: 10.1056/NEJMc1713777.
4
Dihydroartemisinin-piperaquine failure associated with a triple mutant including kelch13 C580Y in Cambodia: an observational cohort study.
Lancet Infect Dis. 2015 Jun;15(6):683-91. doi: 10.1016/S1473-3099(15)70049-6. Epub 2015 Apr 12.
5
Spread of a single multidrug resistant malaria parasite lineage (PfPailin) to Vietnam.
Lancet Infect Dis. 2017 Oct;17(10):1022-1023. doi: 10.1016/S1473-3099(17)30524-8.
6
Emergence of Indigenous Artemisinin-Resistant Plasmodium falciparum in Africa.
N Engl J Med. 2017 Mar 9;376(10):991-3. doi: 10.1056/NEJMc1612765. Epub 2017 Feb 22.
7
Back on TRAC: New trial launched in bid to outpace multidrug-resistant malaria.
Nat Med. 2016 Mar;22(3):220-1. doi: 10.1038/nm0316-220.
8
High Antimalarial Efficacy of Dihydroartemisinin-Piperaquine on the China-Myanmar Border: The Calm Before the Storm.
Am J Trop Med Hyg. 2015 Sep;93(3):436-437. doi: 10.4269/ajtmh.15-0349. Epub 2015 Aug 17.
9
A brief history of artemisinin: Modes of action and mechanisms of resistance.
Chin J Nat Med. 2019 May 20;17(5):331-336. doi: 10.1016/S1875-5364(19)30038-X.
10
Skirmishing over the scope of the threat.
Science. 2016 Apr 22;352(6284):403. doi: 10.1126/science.352.6284.403. Epub 2016 Apr 21.
引用本文的文献
1
Grasp of dihydroartemisinin resistance in Indonesia: Focused on genetic polymorphisms and new antimalarial.
Narra J. 2023 Dec;3(3):e336. doi: 10.52225/narra.v3i3.336. Epub 2023 Dec 11.
2
Susceptibility of Ugandan Plasmodium falciparum Isolates to the Antimalarial Drug Pipeline.
Microbiol Spectr. 2023 Jun 15;11(3):e0523622. doi: 10.1128/spectrum.05236-22. Epub 2023 May 9.
3
Dual-pharmacophore artezomibs hijack the Plasmodium ubiquitin-proteasome system to kill malaria parasites while overcoming drug resistance.
Cell Chem Biol. 2023 May 18;30(5):457-469.e11. doi: 10.1016/j.chembiol.2023.04.006. Epub 2023 May 5.
4
Assessing risks of Plasmodium falciparum resistance to select next-generation antimalarials.
Trends Parasitol. 2021 Aug;37(8):709-721. doi: 10.1016/j.pt.2021.04.006. Epub 2021 May 14.
5
MalDA, Accelerating Malaria Drug Discovery.
Trends Parasitol. 2021 Jun;37(6):493-507. doi: 10.1016/j.pt.2021.01.009. Epub 2021 Feb 26.
6
Amodiaquine resistance in is associated with His95Pro mutation, loss of chloroquine, artemisinin and primaquine sensitivity, and high transcript levels of key transporters.
Wellcome Open Res. 2017 Jun 20;2:44. doi: 10.12688/wellcomeopenres.11768.2. eCollection 2017.
7
Antimalarial drug resistance: linking Plasmodium falciparum parasite biology to the clinic.
Nat Med. 2017 Aug 4;23(8):917-928. doi: 10.1038/nm.4381.
8
K13 Mutations Differentially Impact Ozonide Susceptibility and Parasite Fitness .
mBio. 2017 Apr 11;8(2):e00172-17. doi: 10.1128/mBio.00172-17.
本文引用的文献
1
A surrogate marker of piperaquine-resistant Plasmodium falciparum malaria: a phenotype-genotype association study.
Lancet Infect Dis. 2017 Feb;17(2):174-183. doi: 10.1016/S1473-3099(16)30415-7. Epub 2016 Nov 3.
2
Genetic markers associated with dihydroartemisinin-piperaquine failure in Plasmodium falciparum malaria in Cambodia: a genotype-phenotype association study.
Lancet Infect Dis. 2017 Feb;17(2):164-173. doi: 10.1016/S1473-3099(16)30409-1. Epub 2016 Nov 3.
3
Artemisinin Action and Resistance in Plasmodium falciparum.
Trends Parasitol. 2016 Sep;32(9):682-696. doi: 10.1016/j.pt.2016.05.010. Epub 2016 Jun 9.
4
Identification of a Non-Gatekeeper Hot Spot for Drug-Resistant Mutations in mTOR Kinase.
Cell Rep. 2015 Apr 21;11(3):446-59. doi: 10.1016/j.celrep.2015.03.040. Epub 2015 Apr 9.
5
The effects of chromatin organization on variation in mutation rates in the genome.
Nat Rev Genet. 2015 Apr;16(4):213-23. doi: 10.1038/nrg3890. Epub 2015 Mar 3.
6
Considerations on the mechanism of action of artemisinin antimalarials: part 1--the 'carbon radical' and 'heme' hypotheses.
Infect Disord Drug Targets. 2013 Aug;13(4):217-77. doi: 10.2174/1871526513666131129155708.
7
Artemisinin resistance in Plasmodium falciparum malaria.
N Engl J Med. 2009 Jul 30;361(5):455-67. doi: 10.1056/NEJMoa0808859.
Zotero 插件